Diabetes, obesity & metabolism

Real-World Safety and Effectiveness of Synthetic Semaglutide for Type 2 Diabetes in Pakistan

GLP-1 Therapies Weekly Brief ↗PubMed ↗DOI ↗OA ↗

Updated

Abstract

Biosynthetic semaglutide may improve outcomes for adults with type 2 diabetes mellitus receiving routine outpatient care.

  • The evaluation focuses on real-world effectiveness and safety in a cost-constrained setting.
  • Patient-reported outcomes are also assessed to understand the treatment's impact on daily life.
  • Findings could inform healthcare decisions regarding the use of biosynthetic semaglutide in routine care.

Simplified

Full Text

Full text is available at the source.
View Full Text ↗

Funding

Competing interests

Dr. Arshad Hussain has received honoraria for delivering educational lectures from BF BioSciences. The funding organization provided support for the conduct of this study but had no role in the study design; data collection, analysis, or interpretation; manuscript preparation; or the decision to submit the manuscript for publication. All other authors declare that they have no competing financial or non financial interests.
PubMed

Related papers

Nov '25
Daily oral semaglutide use in adults with type 2 diabetes in Saudi Arabia: a real-world study
top 5% journal
cited by 2 papers
multicenter study
Sep '24
Daily Oral Semaglutide Use in Adults with Type 2 Diabetes: A Real-World Study Across Multiple UK Centers
top 20% journal
cited by 12 papers
clinical trial, phase iv
Mar '25
Daily oral semaglutide's safety and effectiveness in people with type 2 diabetes switching from sulfonylurea medications
top 5% journal
cited by 5 papers
multicenter study
Mar '26
Oral Semaglutide Use and Related Health Results in Thai People with Type 2 Diabetes: Real-World Data from the REALISED Study
journal article
Jan '25
Real-world study of daily oral semaglutide treatment in people aged 65 and older with type 2 diabetes
top 5% journal
cited by 7 papers
journal article
Feb '23
Weekly semaglutide use in people with type 2 diabetes: Real-world results from Italy
cited by 29 papers
observational study
Mar '23
Weekly semaglutide treatment results in adults with type 2 diabetes in France
cited by 25 papers
multicenter study
May '26
Real-life Effects of GLP-1 Medicines on Quality of Life in Type 2 Diabetes and Obesity
journal article
Mar '24
Daily oral semaglutide use and health results in Canadian adults with type 2 diabetes in regular care
cited by 28 papers
multicenter study
Dec '22
Weekly Semaglutide Treatment for Type 2 Diabetes: Real-World Results from the Netherlands
top 20% journal
cited by 23 papers
observational study

What Lands in Your Inbox Each Week:

  • 📚7 fresh studies
  • 📝plain-language summaries
  • ✅direct links to original studies
  • 🏅top journal indicators
  • 📅weekly delivery
  • 🧘‍♂️always free

Recent issues from the glp-1 therapies brief

issue #59
GLP-1 drugs linked to fewer psychiatric hospitalizations in schizophrenia patients with diabetes
2 weeks ago7 studies
issue #58
A new triple receptor drug cut body weight by nearly 20% in 24 weeks
3 weeks ago7 studies
issue #57
A triple-receptor obesity drug just posted 25–35% weight loss in a phase 3 trial
4 weeks ago7 studies
issue #56
Semaglutide cut heart attack risk by 20% — but weight loss explains less than half of it
5 weeks ago7 studies
issue #55
The brain circuit that makes GLP-1 drugs work also causes nausea — and they can't be separated
6 weeks ago7 studies
issue #54
GLP-1 drugs don't build habits — and that gap is costing patients their results
7 weeks ago7 studies
issue #53
Semaglutide slowed aging and extended lifespan in older female mice
8 weeks ago7 studies
issue #52
GLP-1 drugs linked to lower Parkinson's risk in people with type 2 diabetes
9 weeks ago7 studies
issue #51
Semaglutide linked to nearly double the risk of a rare eye condition in people with diabetes
10 weeks ago7 studies
issue #50
A once-daily pill beat placebo on weight loss — and it wasn't semaglutide
11 weeks ago7 studies
explore the archive
See more issues from the glp-1 therapies brief